NCT00128206View on ClinicalTrials.gov

Treatment of Latent TB Infection for Jailed Persons

PHASE3CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

October 31, 2008

Study Completion Date

September 30, 2009

Conditions
Tuberculosis
Interventions
DRUG

Isoniazid

Isoniazid 900 mg twice weekly

DRUG

Rifampin

Rifampin 600mg once per day

Trial Locations (1)

94143-0608

University of California San Francisco, San Francisco

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, San Francisco

OTHER

NCT00128206 - Treatment of Latent TB Infection for Jailed Persons | Biotech Hunter | Biotech Hunter